The SKVs are avian retroviruses that encode the nuclear oncogene, v-ski. These viruses, and retroviruses that express c-ski proto- oncogene cDNAs, transform cells in culture and induce the terminal differentiation of muscle in quail cells that are otherwise incapable of myogenesis. Because mutational analysis failed to separate ski's ability to transform cells from its ability to induce differentiation it is felt that the two activities are mechanistically related, so that analysis of one will provide insights into the other. The present studies will employ constructed avian and murine retroviruses expressing various normal and mutated ski genes to analyze the activity of ski in promoting cellular transformation and differentiation. Studies will include assays for the activation of muscle-specific mRNA transcription and mapping of regulatory regions that respond to ski's activation. Other studies will involve an assessment of ski's indirect action on myogenesis by inducing the developmental commitment of cells to the myogenic lineage by sensitizing them to stimulatory factors or by activating other genes involved in this process. Experiments will also be performed to analyze the expression of individual c- ski mRNAs and their encoded proteins in relationship to cellular proliferation. Monoclonal antibodies generated for this purpose will be used to examine intracellular location and modification of ski proteins in order to correlate these variables with activities of the proteins in promoting in vitro transformation or differentiation and with the induction of tumors in animals. An initial study of ski's possible involvement in human cancer will be made by analyzing the expression and structure of human c-ski in selected tumors with cytogenetic abnormalities at the ski locus and in human squamous carcinoma cell lines.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA043600-08
Application #
3185836
Study Section
Experimental Virology Study Section (EVR)
Project Start
1986-03-01
Project End
1993-09-30
Budget Start
1993-04-01
Budget End
1993-09-30
Support Year
8
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Type
Schools of Medicine
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Zhang, Hong; Stavnezer, Ed (2009) Ski regulates muscle terminal differentiation by transcriptional activation of Myog in a complex with Six1 and Eya3. J Biol Chem 284:2867-79
Atanasoski, Suzana; Notterpek, Lucia; Lee, Hye-Youn et al. (2004) The protooncogene Ski controls Schwann cell proliferation and myelination. Neuron 43:499-511
Johnson, Michael; Morris, Shannon; Chen, Aiping et al. (2004) Selection of functional mutations in the U5-IR stem and loop regions of the Rous sarcoma virus genome. BMC Biol 2:8
Chen, Dahu; Xu, Weidong; Bales, Elise et al. (2003) SKI activates Wnt/beta-catenin signaling in human melanoma. Cancer Res 63:6626-34
Morris, Shannon; Johnson, Michael; Stavnezer, Ed et al. (2002) Replication of avian sarcoma virus in vivo requires an interaction between the viral RNA and the TpsiC loop of the tRNA(Trp) primer. J Virol 76:7571-7
Xu, W; Angelis, K; Danielpour, D et al. (2000) Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. Proc Natl Acad Sci U S A 97:5924-9
Nicol, R; Zheng, G; Sutrave, P et al. (1999) Association of specific DNA binding and transcriptional repression with the transforming and myogenic activities of c-Ski. Cell Growth Differ 10:243-54
Cohen, S B; Zheng, G; Heyman, H C et al. (1999) Heterodimers of the SnoN and Ski oncoproteins form preferentially over homodimers and are more potent transforming agents. Nucleic Acids Res 27:1006-14
Nicol, R; Stavnezer, E (1998) Transcriptional repression by v-Ski and c-Ski mediated by a specific DNA binding site. J Biol Chem 273:3588-97
Cohen, S B; Nicol, R; Stavnezer, E (1998) A domain necessary for the transforming activity of SnoN is required for specific DNA binding, transcriptional repression and interaction with TAF(II)110. Oncogene 17:2505-13

Showing the most recent 10 out of 22 publications